TandemAI raises $35M in Series A for small molecule discovery, wet labs
TandemAI, a small molecule- and preclinical-focused technology company, raised $35 million in a Series A round of financing a little over a year after raising …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
